DHL Global Forwarding doubles capacity at Leipzig Healthcare facility

DHL Global Forwarding has expanded its Life Sciences & Healthcare facility at its Leipzig site by around 2,500 square metres.

The Leipzig site is the second facility in Germany that DHL Global Forwarding has expanded with new equipment and capacity. With the Deutsche Post DHL subsidiary getting recertification of its GxP (good practice) facilities at the three hubs of Frankfurt, Hamburg and Leipzig, this puts DHL Global Forwarding in a strong position to work work on the logistics of importing and exporting COVID-19 vaccinations and other essential medicines.

“Since the start of the pandemic, we have observed a strong increase in demand for pharmaceutical products and goods. Given the good news regarding the development of Covid-19 vaccinations, this demand is likely to increase even further in the coming months,” says Tobias Schmidt, CEO DHL Global Forwarding in Germany. “That is why we prepared for this scenario early on and put everything in place to be able to respond effectively and efficiently. Of course, we also benefit from the fact that DHL Global Forwarding Germany is already very experienced in handling and transporting temperature-controlled pharmaceutical shipments. We have a tight, state-of-the-art network that meets all the strict regulatory requirements in place.”

The Leipzig facility has been more than doubled in size from its original capacity of 2,220 square metres. The new warehouse has two temperature zones – the larger, 1,700 square metre zone has a temperature range that can be fixed between 15 and 25 degrees C. The smaller, 850 square metre zone can be controlled between 2-8 degrees C. It also offers dry ice cooling for passive cooling during transport and handles actively cooled transport containers.

“The current COVID-19 health emergency serves as a reminder to all of us how essential it is to have high quality standards in place for the transportation and storage of drugs and pharmaceutical products. Our customers’ product safety is our top priority, which is why we at DHL attach great importance to continuously improving our service quality. Our IATA CEIV Pharma recertification shows that our efforts are bearing fruit and we are a reliable partner for the shipment of structurally complex and temperature-sensitive drugs,” adds Schmidt.